Sanofi Consumer

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0UOS01011
  • NSEID: SANOFICONR
  • BSEID: 544250
INR
4,217.70
69.1 (1.67%)
BSENSE

Mar 25

BSE+NSE Vol: 17.57 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Alivus Life
Sanofi Consumer
Akums Drugs
Caplin Point Lab
Strides Pharma
Viyash Scientifi
Sanofi India
P & G Health Ltd
Cohance Life
Concord Biotech
Corona Remedies

Why is Sanofi Consumer Healthcare India Ltd ?

1
High Management Efficiency with a high ROE of 76.98%
2
Company has a low Debt to Equity ratio (avg) at 0 times
3
Poor long term growth as Operating profit has grown by an annual rate 11.72% of over the last 5 years
4
With a growth in Net Sales of 7.31%, the company declared Very Positive results in Dec 25
  • The company has declared positive results for the last 2 consecutive quarters
  • NET SALES(Q) Highest at Rs 251.00 cr
  • PBDIT(Q) Highest at Rs 89.80 cr.
  • PBT LESS OI(Q) Highest at Rs 85.90 cr.
5
With ROE of 91.4, it has a Very Expensive valuation with a 37.6 Price to Book Value
  • Over the past year, while the stock has generated a return of -11.47%, its profits have risen by 17% ; the PEG ratio of the company is 2.5
6
High Institutional Holdings at 20.16%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
7
Underperformed the market in the last 1 year
  • Even though the market (BSE500) generated negative returns of -0.34% in the last 1 year, its fall in the stock was much higher with a return of -11.47%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Sanofi Consumer should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Sanofi Consumer for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Sanofi Consumer
-11.12%
-0.33
33.37%
Sensex
-3.52%
-0.27
12.93%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
21.20%
EBIT Growth (5y)
11.72%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.73
Sales to Capital Employed (avg)
2.77
Tax Ratio
25.04%
Dividend Payout Ratio
69.89%
Pledged Shares
0
Institutional Holding
20.16%
ROCE (avg)
-178.66%
ROE (avg)
76.98%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
41
Industry P/E
32
Price to Book Value
37.65
EV to EBIT
31.91
EV to EBITDA
30.70
EV to Capital Employed
138.69
EV to Sales
10.80
PEG Ratio
2.49
Dividend Yield
1.31%
ROCE (Latest)
368.27%
ROE (Latest)
91.45%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Dow Theory
Mildly Bearish
Bearish
OBV
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

24What is working for the Company
NET SALES(Q)

Highest at Rs 251.00 cr

PBDIT(Q)

Highest at Rs 89.80 cr.

PBT LESS OI(Q)

Highest at Rs 85.90 cr.

PAT(Q)

Highest at Rs 66.50 cr.

EPS(Q)

Highest at Rs 28.91

0What is not working for the Company
Icon
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...

Here's what is working for Sanofi Consumer

Net Sales - Quarterly
Highest at Rs 251.00 cr and Grown
each quarter in the last five quarters
MOJO Watch
Near term sales trend is very positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 89.80 cr. and Grown
each quarter in the last five quarters
MOJO Watch
Near term Operating Profit trend is quite positive

Operating Profit (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 85.90 cr. and Grown
each quarter in the last five quarters
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 66.50 cr. and Grown
each quarter in the last five quarters
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Net Sales - Quarterly
At Rs 251.00 cr has Grown at 25.8% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 199.53 Cr
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 85.90 cr has Grown at 27.2% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 67.53 Cr
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 66.50 cr has Grown at 23.8% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 53.72 Cr
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 28.91
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)